Boston Scientific (BSX) EBIT Growth (3y) (2012 - 2026)
Powered by 
Analysis
Boston Scientific (BSX) EBIT Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.58 Bn | 177.98 Bn | 7.27 Bn | 3.16% |
| 2 | Intuitive Surgical | 124.59 Bn | 119.38 Bn | 1.96 Bn | 28.02% |
| 3 | Medtronic | 118.07 Bn | 109.26 Bn | 6.34 Bn | 11.63% |
| 4 | Stryker | 106.00 Bn | 102.52 Bn | 4.50 Bn | 19.80% |
| 5 | Boston Scientific | 66.53 Bn | 65.99 Bn | 3.85 Bn | 31.84% |
| 6 | Edwards Lifesciences | 49.53 Bn | 45.27 Bn | 1.35 Bn | 24.88% |
| 7 | Alcon | 33.90 Bn | 32.44 Bn | 1.68 Bn | -65.59% |
| 8 | Dexcom | 32.17 Bn | 30.22 Bn | 830.00 Mn | 35.44% |
| 9 | Steris | 21.06 Bn | 20.58 Bn | 684.20 Mn | 13.06% |
| 10 | Zimmer Biomet Holdings | 18.31 Bn | 17.90 Bn | 1.54 Bn | -0.36% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 31.84% |
| Mar 31, 2026 | 25.88% |
| Dec 31, 2025 | 27.08% |
| Sep 30, 2025 | 43.05% |
| Jun 30, 2025 | 24.64% |
| Mar 31, 2025 | 25.49% |
| Dec 31, 2024 | 55.36% |
| Sep 30, 2024 | 23.73% |
| Jun 30, 2024 | 25.67% |
| Mar 31, 2024 | 22.19% |
| Dec 31, 2023 | 126.89% |
| Sep 30, 2023 | 75.23% |
| Jun 30, 2023 | 109.84% |
| Mar 31, 2023 | 55.79% |
| Dec 31, 2022 | 24.17% |
| Sep 30, 2022 | -2.22% |
| Jun 30, 2022 | 3.28% |
| Mar 31, 2022 | -4.85% |
| Dec 31, 2021 | -17.37% |
| Sep 30, 2021 | -0.09% |